The primary aim of the project is to map fatigue, cognitive and visual dysfunctions and possible underlying pathophysiological mechanisms in persons with long-term symptoms after a mild to moderate COVID-19 infection. Secondary goals are to study whether covarying factors such as depression and sleep disorders contribute to the results.
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Fatigability from Wechsler Adult Intelligence Scale (WAIS)-IV Coding Test
Timeframe: baseline
Buschke selective reminding test (BSRT)
Timeframe: baseline
Ruff 2&7
Timeframe: baseline
The Delis-Kaplan Executive Function System (D-KEFS) Color-Word Test
Timeframe: baseline
Fatigability on e-prime vigilance task in the fMRI scanner
Timeframe: baseline
Task-based fMRI
Timeframe: baseline
Resting-state fMRI
Timeframe: baseline
Developmental Eye Movement Test
Timeframe: baseline
Visual Motion Sensitivity
Timeframe: baseline
Biomarkers
Timeframe: baseline
Symptom questionnaire
Timeframe: baseline and 1 year and 2 years after the neuropsychological assessment
Multidimensional Fatigue Inventory-20
Timeframe: baseline and 1 year and 2 years after the neuropsychological assessment
The Montreal Cognitive Assessment (MoCA)
Timeframe: baseline and 1 year and 2 years after the neuropsychological assessment